Familial thrombophilia and the occurrence of fetal growth restriction

Haematologica

Volumn 86, Issue 4, 2001, Pages 428-431

  Martinelli, P ^a   Grandone, E ^a   Colaizzo, D ^a   Paladini, D ^a   Scianname N ^a   Margaglione, M ^a   Minno, G D ^a  

^a CASA SOLLIEVO DELLA SOFFERENZA HOSPITAL   (Italy)

Author keywords

A20210 prothrombin allele; Fetal growth restriction; FV Leiden

Indexed keywords

ANTITHROMBIN; BLOOD CLOTTING FACTOR 5 LEIDEN; PHOSPHOLIPID ANTIBODY; PROTEIN C; PROTEIN S; PROTHROMBIN A;

ADOLESCENT; ADULT; ALLELE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; FAMILIAL DISEASE; FEMALE; GENE MUTATION; GENOTYPE; HEREDITY; HUMAN; HUMAN CELL; INTRAUTERINE GROWTH RETARDATION; MAJOR CLINICAL STUDY; THROMBOPHILIA;

ADOLESCENT; ADULT; CASE-CONTROL STUDIES; FAMILY HEALTH; FEMALE; FETAL GROWTH RETARDATION; GENOTYPE; HUMANS; MUTATION; PREGNANCY; PREGNANCY COMPLICATIONS, HEMATOLOGIC; THROMBOPHILIA; VARIATION (GENETICS);

EID: 0035024065     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. A practical classification of newborn infants by weight and gestational age
2. Placental thrombosis and second trimester miscarriage in association with activated protein C resistance
3. Increased frequency of genetic thrombophilia in women with complications of pregnancy
4. Factor V Leiden is associated with repeated and recurrent fetal losses
5. The factor V Leiden mutation may predispose women to severe preeclampsia
6. Hyperhomocysteinemia and venous thrombosis: A meta-analysis
7. A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
8. 20210 mutation
9. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis
10. Increased risk for venous thrombosis in carriers of the FII G→A 20210 gene variant
11. Genetic susceptibility to pregnancy-related venous thromboembolism: Role of factor V Leiden, prothrombin G20210A, and methylenetetrahydrofolate reductase C677T mutations
12. Prothrombotic genetic risk factors and the occurrence of gestational hypertension with or without proteinuria
13. Activated protein C resistance and adverse pregnancy outcome
14. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
15. Coexistence of hereditary homocystinuria and factor V Leiden: Effect on thrombosis
16. A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:QSO6)
17. Thrombophilic genotypes in subjects with idiopathic antiphospholipid antibodies: Prevalence and significance
18. The incidence of the factor V Leiden mutation in an obstetric population and its relationship to deep vein thrombosis